Dr. Rmenapp is based in Wuppertal, Germany and working within the Bayer Pharmaceuticals, Product Supply Biotech Strategy organization, where he is responsible for the development of late-stage assets and launch preparations including the transfer of Bayers pipeline candidates to external manufacturing partners as well as strategy development. Prior to that, Dr. Rmenapp worked in Bayer Biologics Development and was Head of Projects in PS Biotech Contract Manufacturing in Berlin, where he was responsible for contract manufacturing partnerships for biotech products and interdisciplinary project management to ensure market supply. Before it was acquired by Bayer, Dr. Rmenapp hold a similar position at Schering AG, and he started his career in the Production & Logistics department of Schering, where he was responsible for production aspects of in- and out-licensing deals, due diligences, and acquisitions of small molecule products and biologics. Dr. Rmenapp studied chemistry and holds a Ph.D. in biosciences. He worked several years in academic research in the field of biotechnology and as an assistant teacher in general pharmacology.